India covid-19 information India

Minimal impact of Covid-19 2.0 on the Indian pharma industry: ICRA

Reading now: 729
www.livemint.com

“The credit outlook for the Indian pharmaceutical industry remains Stable led by healthy accruals, low leverage levels and healthy liquidity profile of the pharmaceutical companies.

ICRA expects the credit metrics of its sample set of Indian pharmaceutical companies to remain comfortable despite higher capital expenditure and R&D expenses.

Furthermore, the liqudiity profile of these companies is also expected to remain comfortable," Jain said.Never miss a story!

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA